{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:04:58Z","timestamp":1790384698471,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.urolonc.2016.06.001","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T08:17:18Z","timestamp":1467533838000},"page":"452-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non\u2013muscle-invasive bladder cancer?\u2014An International Bladder Cancer Network project"],"prefix":"10.1016","volume":"34","author":[{"given":"Claudia","family":"Schmitz-Dr\u00e4ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Bonberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Pesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Todenh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevim","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd J.","family":"Schmitz-Dr\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2016.06.001_bib1","article-title":"Guidelines on non-muscle invasive bladder cancer Ta, T1 and CIS","author":"Babjuk","year":"2015","journal-title":"Eur Assoc Urol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib2","unstructured":"Hall MC, Chang SS, Dalbagni GT, Pruthi RS, Schellhammer PF, Seigne JD, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1 and Tis: update); 2014. https:\/\/www.auanet.org\/education\/guidelines\/bladder-cancer.cfm"},{"key":"10.1016\/j.urolonc.2016.06.001_bib3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.urolonc.2013.10.010","article-title":"Considerations on the use of urine markers in the management of patients with low\/intermediate risk non muscle-invasive bladder cancer","volume":"32","author":"Schmitz-Dr\u00e4ger","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eururo.2012.09.057","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: screening, diagnosis, and molecular markers","volume":"63","author":"Kamat","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib5","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.eururo.2006.10.046","article-title":"Bismarck E, Ebert T. Immunocytology in the assessment of patients with asymptomatic microhaematuria","volume":"51","author":"Schmitz-Drager","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00345-007-0228-x","article-title":"Immunocytology in the assessment of patients with asymptomatic hematuria","volume":"26","author":"Schmitz-Dr\u00e4ger","year":"2008","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14040","article-title":"Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer","volume":"14","author":"Mowatt","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.urolonc.2016.06.001_bib8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.eururo.2005.03.014","article-title":"Urine markers for bladder cancer surveillance: a systematic review","volume":"47","author":"van Rhijn","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0090-4295(02)02136-2","article-title":"Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and metaanalyses","volume":"61","author":"Lotan","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2016.06.001_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369357","article-title":"Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO\/ICUD consensus","volume":"94","author":"Schmitz-Dr\u00e4ger","year":"2015","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2016.06.001_bib11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.urolonc.2016.05.028","article-title":"Rational follow-up in non-muscle invasive bladder cancer\u2014IBCN recommendations","volume":"34","author":"Kassouf","year":"2016","journal-title":"Urol Oncol."},{"key":"10.1016\/j.urolonc.2016.06.001_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.juro.2009.08.150","article-title":"Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial","volume":"183","author":"van der Aa","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.295.3.299","article-title":"Surveillance for recurrent bladder cancer using a point-of-care proteomic assay","volume":"295","author":"Grossman","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.urolonc.2016.06.001_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00432-012-1297-9","article-title":"Individual risk assessment in bladder cancer patients based on a multi-marker panel","volume":"139","author":"Todenh\u00f6fer","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00420-013-0916-3","article-title":"Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines","volume":"87","author":"Pesch","year":"2014","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.urolonc.2016.06.001_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1309\/ADJL7E810U1H42BJ","article-title":"Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings","volume":"127","author":"Yoder","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.urolonc.2007.02.011","article-title":"The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancer","volume":"26","author":"Gofrit","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib18","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","article-title":"Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data","volume":"64","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib19","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.eururo.2006.10.044","article-title":"UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer","volume":"51","author":"Moonen","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.juro.2009.02.142","article-title":"Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker","volume":"182","author":"Lotan","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00345-007-0228-x","article-title":"Immunocytology in the assessment of patients with asymptomatic hematuria","volume":"26","author":"Schmitz-Drager","year":"2008","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-5347(05)65386-4","article-title":"Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach","volume":"167","author":"Lotan","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.06.001_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1464-410X.2008.08323.x","article-title":"Non-muscle-invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost-effective alternative?","volume":"104","author":"de Bekker-Grob","year":"2009","journal-title":"BJU Int"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916301181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916301181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:09:16Z","timestamp":1761041356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143916301181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1078143916301181"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.06.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non\u2013muscle-invasive bladder cancer?\u2014An International Bladder Cancer Network project","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}